Ten journalists have been chosen for the third class of the AHCJ Fellowship on Comparative Effectiveness Research. The fellowship program was created with support from the Patient-Centered Outcomes Research Institute to help reporters and editors produce more accurate in-depth stories on medical research and how medical decisions are made.
The fellows will gather in Washington, D.C., the week of Oct. 15 for a series of presentations, roundtables, how-to database sessions and interactions with researchers.
Find out who was awarded fellowships and learn more about the program.
No fewer than four of the 2016 winners of the Awards for Excellence in Health Care Journalism covered the opioid epidemic from different angles. No surprise — former Surgeon General Vivek Murthy noted last year that more Americans suffer from addiction than from cancer. During his tenure, Murthy made the opioid crisis a top priority.
Murthy’s 2016 report on addiction has been compared to an influential report on smoking decades earlier, and he created a website devoted specifically to addressing the opioid crisis. But how much of it could have been prevented with a bit less complacency on the part of researchers? Continue reading
President Donald Trump’s budget proposal includes rolling a relatively obscure agency that conducts health care research into the National Institutes of Health, and cutting the NIH budget by $5.8 billion.
That small agency – the Agency for Healthcare Research and Quality, or AHRQ (pronounced “arc“) – could be cut entirely or see its mission shrink drastically under the president’s plan. Reducing or eliminating AHRQ would have a significant effect on health system research and health IT adoption in communities across the country. Reporters have a number of ways to see how changes to AHRQ could affect health services in their region. Continue reading
The potential benefits of genetic testing are widely touted and drive greater interest in these tests – even though the validity of the science behind such testing remains unclear.
Charles Piller, the West Coast editor for Boston-based online news site Stat, recently reported on the lack of a firm scientific basis for a test that Proove Biosciences in Irvine, Calif., has been marketing as an “opioid risk” detector. Continue reading
At Health Journalism 2016 in Cleveland, Andrew M. Seaman and Hilda Bastian discussed shortcuts for weighing the likelihood a study’s answer is right, making sense of shifting bodies of evidence and cutting through researcher spin. Continue reading